Key facts
- It has raised $60K; the latest was Early Stage VC in Dec 2025.
- Notable investors include SOSV, Start-Up Chile, The Think & Act Differently, AIR Capital, Columbia Business School — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Giraffe Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Giraffe Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Giraffe Bio
Developer of a biomining technology designed to improve the efficiency and sustainability of metal extraction. The company offers AI-optimized biomolecule engineering, cell-free systems and proprietary screening tools, enabling mining companies working with low-grade or complex ores to increase metal yields, reduce environmental impact, and lower operational costs.
- Sector
- Information Technology
- HQ
- Buenos Aires, Argentina
- Founded
- 2024
- Employees
- 7
- Website
- giraffe-bio.com/
- Ownership
- Privately Held (backing)
Giraffe Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Giraffe Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Giraffe Bio in its N-PORT filings yet. We sweep new filings monthly.